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1. Introduction 
1.1 Different samples may have differing cryopreservation requirements 
For any cryopreservation protocol there are five key questions that govern the methodology 
and logistics of the freezing and storing process. 
 What is to be stored? 
 How many batches are to be stored? 
 What is the expected duration of storage? 
 What properties are the retrieved samples required to possess? 
 Are there packaging requirements in addition to those dictated by the 
cryopreservation process? 
Reduction of temperature results in the retardation of metabolic processes and this can, in 
some circumstances, provide sufficient stability for the required period of storage. However, 
at temperatures below 0 °C the biological effects of cooling are dominated by the 
crystallization of ice: typically, water constitutes around 80 % of tissue mass. Freezing is the 
conversion of liquid water to crystalline ice but the term is commonly misused in 
circumstances where samples are cooled below their expected freezing point but without 
the formation of ice, for example by supercooling or by vitrification. The result of the 
freezing of water in a complex solution is that the concentration of the solutes in the 
remaining liquid phase increases and some solutes may precipitate if their concentration 
exceeds their solubility limits. This realisation provides two potential mechanisms of 
damage: direct mechanical effects of the formation of ice, and the rise in concentration of 
dissolved solutes.  
In 1948 a method was discovered that permitted the freezing of many types of animal cells 
with good post-thaw recovery of living cells: Polge, Smith, and Parkes (1948) showed in a 
landmark paper that adding 10-20 % of glycerol enabled avian spermatozoa to survive 
freezing at -80 °C. Theories of freezing injury that were current at the time envisaged ice 
crystals damaging the cells and intracellular structures, and because glycerol increased the 
total solute concentration in the system, the amount of ice that formed was reduced. A little 
later, in the 1950s, Lovelock (1952) showed that the increase in concentration of salts as the 
volume of the suspending solution decreased was in fact the dominant damaging 
mechanism: salt concentration, rather than ice formation, was a major cause of freezing 
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injury to cells. Subsequently other cryoprotectant solutes were explored along with different 
rates of cooling, resulting in solidification of the stored samples but with a range of mixtures 
of ice and vitrified solid in the stored samples. 
The physical nature of the sample dictates the thermal transfer characteristics of the cooling 
process for that specific sample and either the physical size or cell-type will affect the 
appropriate cooling rate and other parameters of the cryopreservation protocol. Similarly, 
the physical type and ultimate intended use of the sample (for example dose requirement in 
the case of future therapeutic use) will determine the size of the individual packaging. An 
additional layer of packaging may be necessary to prevent microbiological contamination – 
so-called ‘double bagging’. Likewise the ultimate destination of the sample will also dictate 
the care required during the freezing process and the conditions necessary for long-term 
storage. Some tissues and most larger biological samples are currently difficult or 
impossible to cryopreserve successfully and new techniques, such as Liquidus Tracking 
(discussed later in this chapter) may address some of the problems associated with 
cryopreservation of these types of sample. 
It is sometimes the case that the ultimate use of the samples stored is not known at the time 
of the initial collection and storage and sometimes the significance of particular samples 
may change with time. However, in many cases, the potential of the stored samples is fixed 
or limited at the time of selecting the cryopreservation and storage methods. The 
importance of these choices will be covered later; however it is pertinent to note here that 
the storage process may have an important impact on the value of samples when they are 
recovered from storage; changes in the properties of the recovered samples may be 
irreversible and this is therefore a key to maximising the sample's potential. 
The term “viability” is frequently used in the context of cell and tissue banking. Strictly 
speaking it means the potential to exhibit the signs of life at some future stage, whereas it is 
often misused to mean the extent to which a sample demonstrates attributes of life at the 
present time. But that is “vitality” not “viability.” However, it is also the case that not all the 
attributes of life are exhibited by all living things, and the possession of one attribute does 
not imply the presence of them all. In fact, few of the properties that characterise “life” can 
be measured quantitatively. The term is best avoided; functional measurements should be 
named to describe what they actually measure: membrane integrity; a specified  metabolic 
function; ability to reproduce. In addition there are obvious cases where the tissue does not 
have to be alive in order to function; in bone for example. But equally, in many cases fully 
functional survival is paramount; the haemopoietic stem cells in cord blood will not graft in 
the recipient if the cell concentration is lower than a threshold value. In such cases a low 
total recovery of living cells in the thawed sample will limit the use of the thawed sample. 
Another common situation is where samples are stored in order to ensure that a supply of 
identical cells will be available throughout a long-term study. Although it is possible to 
regrow new cell batches from recovered samples, repeating this process can lead to 
progressive degradation due to mutations. 
1.2 The physics of freezing 
The process of freezing is ultimately simple; it is merely the application of an environment 
that removes energy from the sample over a period of time and changes the physical state of 
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water in the sample from liquid to crystalline. Crystalline water (ice) excludes the solutes 
previously dissolved in the water, resulting in two potentially dangerous mechanisms – 
direct effects of ice and secondary effects in the solute composition. At a sufficiently low 
temperature all biological activity is prevented and the physical state of the sample is 
preserved. In simple cases, where the only requirement is to preserve the physical state or 
where cellular structure is absent (viruses, DNA etc.), that is the end of the story; physical 
deterioration can be prevented at relatively high temperatures, and in many institutions 
worldwide this task is completed in the banks of -80 °C refrigeration units that proliferate in 
medical and biological research establishments.  
The preservation of living cells and tissues and the post-thaw ability of cells to proliferate 
and thrive are determined by a number of factors: the laboratory techniques and the 
thermodynamic processes that a sample experiences during processing and freezing; the 
environment in which it resides between freezing and the ultimate use post-thaw. The 
potential of many samples is severely limited at this stage by the choices made by, or 
enforced upon, the technician regarding the freezing protocol. It may be that some stored 
samples lose significant value due simply to the omission of a few simple additional steps. 
The cryopreservation process has two main aims. The first is to reduce the temperature of 
the sample to a point where biological stability is achieved. The application of an external 
cryogenic environment will remove energy from the sample and create a very low-energy 
solid state within which biological and chemical activity are limited or prevented altogether. 
The second is that during the freezing process it is necessary to prevent the formation of 
intracellular ice crystals: such crystals damage the cellular structure and can lead to limited 
post-thaw recovery and post-thaw failure of the cell sample to function as required. 
Additionally, the protocol must take into account the stresses to which the cells are exposed 
during the freezing process (dehydration, hypothermia, chemical toxicity, and solute 
concentration) and the potential for an apoptotic response post-thaw. 
The objective, therefore, is to create an environment in which, as the sample is cooled, the 
chemical composition inside the cell, is managed in such a way as to create an intracellular 
composition with a lower freezing point than the applied environment, whilst maintaining 
an external suspending composition that is able to solidify at the same temperature. The 
balance between the internal and external environment is managed chemically via the 
solutes in the micro-environment and thermodynamically via the application of an energy 
reducing (cooling) macro-environment. It is the combined action of these two factors that 
determines the success or otherwise of a cryopreservation protocol for the conservation of 
vitality. 
The appropriate solute composition is created by including cryoprotective agents (CPAs) in 
the medium. These operate in one of two ways: either they modify the extracellular 
composition or alternatively they also replace some of the intracellular water. The first 
mechanism involves the addition of non-penetrating CPAs such as trehalose, polyethylene 
glycol (PEG) or Polyvinyl-pyrrolidone (PVP), to the medium. The second mechanism 
requires the addition of penetrating solutes that can traverse the cell membrane, such as 
glycerol, ethylene glycol and dimethyl sulphoxide (DMSO). Since water does not retain 
solutes when it freezes, a solution at equilibrium with ice will vary in osmotic potential as it 
freezes and because of this, the micro-environment of a cell will require either the cell to lose 
water to the environment or exchange water for CPA molecules, thereby maintaining 
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osmotic balance. The concentration of intracellular material lowers the effective freezing 
point of intracellular material and, provided the external temperature is correctly managed, 
prevents the formation of intracellular ice. As such, the creation of ice crystals within the cell 
is avoided. At temperatures below -130 °C (close to the glass transition temperature of the 
medium) the residual liquid has too little energy to orientate into long range molecular 
matrices and will form short range semi-solid structures; i.e. an amorphous solid or glass. At 
this point there is no possibility for significant chemical transport; biological activity, and 
hence deterioration, effectively ceases. 
The options for control of this process are the chosen CPA and its concentration, and the 
cooling rate. Water and solute permeability are temperature dependent and nominally the 
higher the concentration of extracellular CPA, the less ice will form during cooling. With a 
very high applied concentration of CPA, very rapid cooling without the formation of ice 
may be possible – a process that is known as vitrification. At the other extreme, lower CPA 
concentrations that allow ice to form, require more precisely managed cooling rates which 
can be provided by programmable controlled rate freezers. The issue here is the toxicity of 
the applied CPA since high concentrations, even for short periods, can lead to excessive 
dehydration and high cell stress, whereas lower concentrations may involve prolonged 
cellular exposure to essentially toxic material. DMSO, for example, is an organic solvent and 
has been linked to cellular mutation. The choices made for the preparation and subsequent 
freezing of cells is a complex balance between thermodynamic and biochemical variables, 
the choice and management of which can have a profound effect on the post-thaw recovery 
of living cells and hence the value of the sample. 
1.3 Long term cell survival and contamination 
All biological materials will, without intervention, naturally deteriorate, and if they are to be 
preserved it is necessary to utilize a method that will preserve both morphology and 
functionality while preventing any alteration of the fundamental nature of the material. The 
most common methodology available for this is cryopreservation. Biological materials, 
however, have widely different properties and in order to create a truly effective 
cryopreservation protocol, it is necessary to consider these properties as they affect the 
preservation of vital characteristics both during the freezing process and the subsequent 
environment in which the samples are to be stored long term. 
Regarding the minimum storage temperature, no temperature is too cold. Once a sample is 
frozen and the residual liquid phase has vitrified, further cooling simply reduces molecular 
energy and vibration. It is possible for short-range structural changes to occur at a molecular 
level, but they do not affect post-thaw biological properties. It is worth noting that because 
the cell micro-environment within a frozen sample is chemically different from the majority 
of the frozen material, biological activity may continue, albeit slowly, at temperatures 
several degrees below the freezing point of the material.  
The minimum melting point of the multi-dimensional phase diagram for typical 
cryopreservation media occurs at around -80 °C but the cell contents do not finally solidify 
to an amorphous state until around -120 °C. It is not sufficient simply to keep the samples 
frozen because, at a micro-environmental level, if the material retains the ability to diffuse it 
may also degrade, albeit at a much reduced rate. The glass transition temperature is 
therefore regarded as the “critical” temperature if truly long term storage is required 
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Best practice dictates that freezers should maintain sample temperatures as far as possible 
below this critical temperature. By storing well below the critical temperature, transitory 
warming events above that temperature can be avoided during sample handling, retrieval, 
storage and in the event of any disruption to the availability of cryogen or power. Freezing a 
sample in such a way as to maintain maximum biological potential is not a trivial task, and 
the same care applied to this process should be brought to bear when designing and 
building storage environments. 
The key considerations when looking at a cryopreservation process were listed at the 
beginning of this chapter. Clearly, the process should be able to maximise the potential for 
use after processing and storage. Because the future use may be unclear, the preservation 
and storage procedures should be designed to provide the best possible opportunity for 
future exploitation. The storage of cells without either adequate care during the initial 
cryopreservation process or at too high a temperature during subsequent long-term storage 
are key problems that should be avoided and when the purpose of storage is to maintain 
biological potential, it is vital that the mechanism of freezing injury be considered.  
As the liquid in which the cells are suspended begins to freeze, any solutes in the unfrozen 
solution become more concentrated and this results in a depression of the freezing point of 
the remaining solution. The result of this, when the temperature is reduced, is that the cells 
are exposed to a solution of progressively higher concentration. The increasing 
concentration increases the osmotic gradient across the cell membrane which results in 
water leaving the cell in order to maintain balance. Hence, controlling the cooling rate 
provides a mechanism for controlled dehydration of the cells. Eventually the aqueous phase 
is so viscous that there is insufficient energy available for the water molecules to form a 
crystalline solid and the solution becomes an amorphous solid or glass. The temperature at 
which this condition is reached is known as the “glass transition” temperature (Tg). Once 
the sample is below this temperature, diffusion within and without the cell stops and the 
sample is biologically inert. At temperatures below Tg the sample can be maintained 
indefinitely; other physical interactions, such as background radiation, may have an impact 
on extremely long-term storage but such effects are probably without any significance in 
practice (Glenister et. al., 1984).  
Unlike freezing, the glass transition is not based upon a thermodynamically defined phase 
change but rather on the observed dramatic change in viscosity that occurs in cryoprotectant 
solutions typically at around -120 °C. It is important to ensure that samples are maintained 
below this temperature throughout the storage term. A temperature of -150 °C is typically 
stated to be the critical storage temperature for cell products since this temperature provides 
a reasonable safety margin to ensure that that samples remain below the glass transition 
temperature during transitory events such as handling, but in practice, storage in liquid 
nitrogen at -196 °C is a convenient and reliable way to meet this requirement; moreover the 
additional safety margin provides even greater sample security. 
However, storage in liquid nitrogen is not without its disadvantages which include the risk 
of explosion during warming should liquid nitrogen have entered the vials. Microbiological 
cross-contamination is another hazard of storage in liquid nitrogen (Byers, 1999) and may 
lead to the application of a secondary enclosure (‘double bagging’). Storage in the gas phase 
has been advocated to avoid these problems. In the past, the temperature gradient in the 
vapour phase of liquid nitrogen refrigerators has been a problem, and there may have been 
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increased vulnerability to inadequate amounts of liquid nitrogen between refills. Modern 
high-efficiency liquid nitrogen cooled vessels now allow storage in the vapour phase 
without these problems. These vessels are vacuum insulated and the surface area that is not 
insulated by the vacuum is minimised ensuring that the evaporation rate of liquid nitrogen 
is kept low. Restricting the amount of energy entering the vessel ensures that the 
temperature in the vapour phase is maintained close to the liquid nitrogen temperature. The 
upper region of the refrigerator, close to its access point where the temperature would 
otherwise be higher, can be efficiently cooled if it is ensured that the heat exchange surface 
extends right from the bottom to the top of the refrigerator: gas phase temperatures of 
around -190 °C can be achieved.  
The weak point in the process of maintaining safe low temperatures for samples focuses on 
the time in transport to and from its storage. Small samples of low thermal mass, such as 
vitrified straws, can warm at the rate of thousands of degrees Celsius per minute and 
regulatory inspections requiring the removal of samples for identification can be another 
weak point. 
1.4 Traceability 
Under most regulatory environments, a rigorous sample tracking system is a key and 
mandatory component of compliance. It is vital that the individual location of any sample is 
recorded accurately, and that the sample is labelled with a unique identifier such that the 
identity of a sample at any location can be verified. For many research and therapy 
provision operations it is also necessary to have all processing, analytical and, if relevant, 
patient data linked in a central database.  
Labelling can be a challenge as sample containers can be small and the cryogenic 
environment hostile; however commercially available cryogenic-proof labels and label 
printing systems are readily available. RFID tags are also a promising solution. 
Sample location databases should be organized hierarchically, such that the location of any 
individual sample can be readily identified; for example: Room / Freezer / Shelf; or 
Segment / Rack / Position of Box in Rack / position of Vial in Box; or Room / Freezer / 
Canister / Cane / Goblet / Straw position in Goblet. 
Most regulatory environments require the label to include both machine and human 
readable identifiers (bar code plus text) and where a sample is stored in a secondary 
container (such as a blood bag in a cassette) it is vital that both the external container and the 
primary sample container be correctly labelled; see for example the European Directives 
2004/23/EC and 2006/86/EC 
Concomitant with good identification procedures are good location and retrieval methods 
and there are a number of commercial software systems available with varying degrees of 
sophistication to accommodate larger or smaller numbers of stored samples. However an 
often overlooked part of the storage process is the logging, monitoring and associated 
alarms. Recording the parameters of storage is sometimes seen only as a regulatory 
obligation but liquid nitrogen levels or temperatures and the performance of mechanical 
freezers is of front-line importance. Alarms that work in practice rather than in theory are 
vital additions to a comprehensive storage environment. 
www.intechopen.com
 
Precision in Cryopreservation – Equipment and Control 
 
513 
2. Types of technique 
There are various options to consider when choosing the methodology and equipment for 
the cooling process. In conventional cryopreservation, where the intention is to control the 
rate of formation of ice in the material, it is necessary either to vary the rate of application of 
a cryogen when working against a constant warm environment, or to provide insulation or 
energy while maintaining a constant external cold environment. If insulation is used, the 
cooling rate at any point is approximately proportional to the difference in temperature 
between the sample and the environment as modified by the insulation and the change in 
specific heat of the sample as cooling proceeds. Thus, during the process, the cooling rate 
asymptotically approaches zero as thermal equilibrium is achieved. Applying variable 
energy to a sample in a cold environment allows the rate of cooling to be modified during 
the process. The aim is to maintain a composition within the cells that varies as cooling 
proceeds such that its freezing point remains below the applied environmental temperature. 
Alternatively, if the concentration of cryoprotectant is high enough, it may be possible to 
cool the sample sufficiently rapidly that ice cannot form – an approach called vitrification. 
The required cooling rate will depend on the cryoprotectant and its concentration, the latter 
being dependant on the concentration that the cells will tolerate. In general, very rapid but 
uncontrolled cooling is used. The new technique of liquidus tracking allows slow cooling 
and vitrification. 
2.1 Freezing in mechanical freezers 
Passive cooling uses insulation to moderate the cooling rate of samples that have been 
equilibrated with low concentrations of cryoprotectant and then placed inside traditional 
electromechanical refrigerators at -20 °C, -40 °C, -80 °C or even at lower temperatures. The 
cells are dessicated slowly during the cooling process. This method can be used for most 
robust cells but even under the best circumstances the post-thaw recovery rates may not be 
ideal. In addition, in most cases no instrumentation monitoring or recording of the process 
is provided. The variation of temperature within mechanical refrigerators is well known 
with one study reporting values of -43.5 °C to -90 °C in upright freezers (Su et. al., 1996). 
Since there is no active control during the process, it follows that the poor repeatability of 
the process can affect the cooling rate and hence the efficiency of the whole procedure. 
Variability might be improved if the local environment were more stable and protected from 
instantaneous variation due to external factors such as door openings etc. It is generally 
preferable to use a liquid nitrogen gas phase freezer for this approach since the internal 
temperature variation is small and the environment disturbed less frequently.  
This approach to cooling and freezing is increasingly being used for material provision in 
pharmaceutical drug screening programmes as they move from supply by continuous 
culture towards a “cells-as-reagents” concept. In this approach, the cells are insulated in 
polystyrene containers as they are cooled initially to -80 °C and then transferred for 
cryogenic storage into liquid or vapour phase nitrogen. The need for rapid use of the cells 
for drug assays following cryopreservation, places an increased importance on the post-
thaw quality of the cells. In recent work carried out at LGC (Teddington,UK) this has been 
shown to be compromised by this type of freezing where the cooling rates are not actively 
controlled but rely on the passive characteristics of the system. In particular, temperature 
fluctuations within the polystyrene container and the storage time at -80 °C can significantly 
impact the post-thaw recovery of the cells and their biological function.  
www.intechopen.com
 
Current Frontiers in Cryobiology 
 
514 
2.2 Controlled freezing, protocols and seeding 
Liquid nitrogen may be applied via a pressurised supply and cryogenic valve to create a 
very accurate cooling profile of temperature over time. This methodology offers the most 
options for optimization since the cooling rate can be varied at multiple stages in the 
process. As freezing proceeds the concentration of solutes in the medium increases causing 
cell dehydration in the sample.  
As described in the opening section, cooling protocols are designed to manage the intracellular 
solute concentration. The key point is the nucleation temperature of the suspending medium - 
that is, the temperature at which ice starts to form. The ice is extracellular, resulting in an 
increase in the extracellular solute concentration and and hence an osmotic pressure difference 
between the intracellular and the extracellular solutions that leads to the withdrawal of water 
from the cells. It is important to recognize that under normal circumstances, solutions do not 
freeze at their freezing point; they freeze at their nucleation temperature, which is variable and 
depends on the availability of nucleation centres in the sample. The nucleation temperature is 
normally several degrees below the nominal freezing point. 
Once the extracellular fluid begins to freeze, two major events occur. First, as explained 
above, the concentration of CPA increases in the fraction of the extracellular fluid that has 
not at this point frozen, and this causes the cells to dehydrate. Secondly, the temperature of 
the suspension where freezing has commenced rises towards the nominal freezing 
temperature and remains at or close to this temperature until the freezing process is 
complete. This is followed by a drop in temperature as the sample catches up with the 
temperature of the surrounding medium, but if the cooling rate is too rapid the intracellular 
CPA concentration may be insufficient to prevent intracellular freezing – with severe 
consequences for the cells 
In order to avoid this hazard, the control program may be designed to allow equilibration of 
the sample and its suspending medium at a temperature marginally below the calculated 
freezing point and at this temperature the sample forced to begin to freeze by applying either a 
physical nucleation point via a cold instrument placed on the external wall of the sample 
container, or via a sudden, short-lived introduction of cryogen into the environment. This 
causes the sample to commence freezing. As the sample was originally held only marginally 
below the nominal fusion temperature, the cell experiences a much more moderate reduction 
in temperature when the fusion is complete and the temperatures re-equilibrate. After this, the 
cooling processes is started and continues with a temperature program that is designed to 
effect the necessary concentration changes to maintain the intracellular composition in the 
liquid region of the phase diagram. This process is called “seeding”. 
2.3 Vitrification 
The process of vitrification usually uses the highest concentration of cryoprotectant that the 
cells in the tissue will tolerate and follows this by very rapid but uncontrolled cooling, 
usually by plunging the sample into liquid nitrogen. The crucial element is exposure of the 
cells or tissue to potentially toxic levels of CPA: too low a level or too short a time and ice 
will form killing the cells. If the levels are too high or the process time is too long, the 
chemicals employed will prove toxic to the cell and post-thaw viability will be limited. Since 
this process depends on rapid cooling, vitrification has only ever proven applicable for 
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samples with very small volumes, ideally those with very high surface area-to-volume 
ratios; for example cryogenic straws can fit this description. It is important to be aware of 
the Leidenfrost effect where a sheath of vapour will surround a warm sample when 
plunged into liquid cryogen, essentially insulating the sample for a short period of time. For 
many vitrification protocols however, even this short additional time period before the 
sample is vitrified has proven fatal to the cells due to increased toxic exposure to the CPA 
and decreased cooling rates. In conventional vitrification, very high cooling rates are 
achieved by exposing small samples directly to the liquid nitrogen. The sample is 
surrounded with as little physical material as possible to achieve the maximum cooling 
rates. With large samples, however, such high cooling rates are impracticable.  
Although vitrification is normally associated with cooling rates in the tens of thousands of 
degrees Celsius per minute, slower techniques have been reported such as the S3 
vitrification technique for blastocysts (Stachecki & Chen, 2008); this uses rates 
<200 °C/minute. But in fact vitrification does not necessarily require rapid cooling at all. It 
all depends on the dependence of the critical cooling rate required to prevent freezing on the 
concentration of the cryoprotectant. (Sutton, 1991). As the following section describes. 
vitrification can be produced at really low cooling rates. 
2.4 Warming and thawing 
It is usual to thaw cryopreserved or vitrified samples rapidly – typically by plunging them in a 
37 °C water bath. The warming rate does have an effect on the recovery of living cells but this 
is not as great an influence as cooling rate is during cooling. In fact, optimum cooling rates 
have usually been determined using rapid warming so it is hardly surprising that rapid 
warming then gives the highest recovery! However, there are circumstances when the 
warming rate is of importance in its own right. The first is when the sample has been vitrified 
but is nucleated without a significant amount of ice being present. This is an unstable situation 
and in such circumstances the warming must be rapid to avoid intracellular freezing during 
warming. This consideration argues for rapid warming. The other situation occurs when the 
frozen material contains a significant amount of vitrified material, as is always the case in 
conventional cryopreservation. Glasses are brittle and the hazard here is that rapid warming 
will generate thermal stresses and cause the vitreous material to fracture. This will not matter 
greatly with cell suspensions where a fracture running through the sample is unlikely to 
traverse many cells but it is very important when the extracellular matrix must be intact – as it 
must, for example, in grafted blood vessels and heart valves. The solution here is to warm 
through the vitreous zone, that is from -196 °C to -123 °C,  relatively slowly: once above the Tg 
there is no hazard from fractures and the sample can be warmed as rapidly as you like. A 
convenient way to do this is to allow the sample to warm slowly in a -80 °C refrigerator or 
packed in solid CO2 until its temperature is at above -100 °C. Alternatively the sample can be 
surrounded by a layer of insulation during the initial stage of warming in room air. A 
warming rate of around 50 °C/minute up to -100 °C was ‘slow’ enough to prevent fractures in 
cryopreserved rabbit carotid arteries (Pegg et al., 1997). 
2.5 Liquidus tracking – A new method 
The controlled-rate freezing process achieves its results by preventing the formation of 
intracellular ice. In some samples, however, even extracellular ice can be severely damaging. 
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An example of this is articular cartilage. Isolated chondrocytes can be cryopreserved using 
conventional techniques (Pegg et. al., 2006a) but results when attempting to cryopreserve 
chondrocytes in situ have proven to be very disappointing. It was found that traditional 
cryopreservation results in the formation of ice crystals within the chondrons and not just in 
the acellular matrix (Pegg et. al., 2006b) which might have been expected from experience 
with conventional cryopreservation. In articular cartilage it is important to prevent both 
intracellular and extracellular ice. With this requirement in mind, the most appropriate 
cryopreservation approach would appear to be vitrification; that is the prevention of any ice 
formation at all. However, it will be clear that conventional vitrification is out of the 
question because of the heat transfer problems with bulky samples. Liquidus tracking (LT) 
provides a new approach to this problem.  
During conventional cryopreservation, with a moderate concentration of CPA (say 10 %w/w) 
and relatively slow cooling (say 1 °C/minute), the cells are exposed to gradually increasing 
concentrations of cryoprotectant as progressively more extracellular ice is formed. The 
instantaneous CPA concentration is determined by the temperature according to the phase 
diagram of that specific system. The idea of LT is to control the instantaneous concentration of 
CPA throughout the cooling process so that the CPA concentration follows the liquidus line by 
external control rather than by progressive freezing of the medium. In this way the medium 
remains just above its freezing point at all times and no ice is formed. It is important to note 
that the cells are exposed only to the concentrations of CPA that they would experience during 
conventional cryopreservation. And we know that isolated chondrocytes in suspension can be 
cryopreserved by standard methods. In effect, the LT process takes advantage of the decrease 
in cytotoxicity of cryoprotectants as the temperature is decreased: hence, rather than starting 
with a very high concentration of cryoprotectant, the LT approach controls the concentration 
dynamically throughout the cooling process. In this way, vitrification can be achieved without 
using the extremely high concentrations of cryprotectant at the start of the process and without 
the need for rapid cooling. Of course, allowance has to be made for the time that diffusion of 
CPA into the tissue takes and this can be very considerable. On the other hand, if an organ can 
be perfused with the cryoprotectant solution, via the vascular system during cooling, then the 
diffusion distances will be very short and mass transport delays much less significant. In 
practice, when designing an LT process for a particular tissue, it is crucial to determine the 
concentration that is actually achieved in the tissue as the process continues and to adjust the 
concentration/ temperature/ time program to achieve the desired tissue concentration at all 
stages of the process. This necessitates slow cooling, commonly of the order of 0.1 to 0.3 °C per 
minute. The cooling of the samples can be achieved in a conventional controlled rate cooler 
and the solution composition can be controlled by standard peristaltic pumps, the whole 
system being under computer control – see section 3.7 below for a discussion of the methods 
that are now available for research use. 
3. Types of equipment 
Due to the many different types of samples that can be cryopreserved and their differing 
sensitivities, a number of different techniques and types of equipment are used. 
3.1 Minus 80 °C and lower: Mechanical freezers 
Mechanical refrigeration always applies the same methods no matter the degree of cooling 
desired: a gas is passed through a compression system and liquefied. The energy which is 
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released during this liquefaction is dissipated to the environment via heat exchanger coils. 
The liquid is then passed through cooling coils within the freezer chamber and absorbs 
energy from the chamber as it vaporizes. It is the vaporization process that creates the 
cooling effect. As lower temperatures are required, lower liquid point gases must be 
employed. In order to liquefy these gases, higher pressures are required and often the 
liquefaction cannot be completed in a single process; this results in larger, multiple 
compressors being employed.  
The most commonly used freezers for cryogenic purposes are upright, front-opening 
freezers with a cold point at a nominal -80 °C. It should be noted that there is no biological 
significance for this temperature, merely a physical significance since it approximates to the 
sublimation temperature of dry ice (solid carbon dioxide, -79 °C). This type of freezer can be 
employed to store biomaterial in which living cells are not a prime concern, or when it is to 
be stored for only a short period of time. This type of equipment is intended to be for 
transactional storage – holding material required daily and which will either be consumed 
or transferred to more appropriate conditions within a short time - 6 to 12 weeks typically. 
The front opening design, while adding considerable convenience, creates a significant issue 
with temperature stability and variability. Because cold air is significantly heavier than 
warm air, opening the door causes massive air exchanges and temperature rises in the 
sample area in a short period of time. In addition, because the compressor systems run on a 
very high cycle time, there is little spare capacity to effect a cooling after the temperature has 
risen and it can take some time to return to equilibrium after a warming event. This 
property is similarly exhibited when the freezer is in normal operation and as has been 
previously noted, there can be significant temperature variations. The use of deep drawers 
within the refrigerator for the storage of samples is helpful in reducing the loss of cold air 
when the door is opened.  
Because of the high cycle times, compressor failures are quite common and expensive to 
repair. It should also be noted that as the energy removed from the sample area is 100 % 
dissipated into the room in which the freezer is located, the term cost of operating a unit 
such as this should take into account not only the electricity consumption required for the 
compressor system, but also the significant air conditioning costs associated with the 
expelled heat from the freezers. If this energy is not removed by air-conditioning, the 
freezers become less efficient as room temperature rises, compressors are required to cycle 
even longer, power usage rises and compressors fail more quickly. Environmental 
management at a macro as well as micro level is therefore important. 
3.2 Alcohol bath freezers 
These commonly used laboratory units are essentially refrigerated circulators. A reservoir of 
cooling medium (normally an alcohol) is passed through a cooling system and re-enters a 
reservoir, reducing the temperature. The degree of refrigeration applied and the flow rate 
through the cooling coils determine the derived temperature of the reservoir. The relatively 
large volume of cooling liquid creates two noticeable effects: temperatures are very stable 
due to the large heat capacity of the available fluid and cooling rates can be controlled very 
accurately for a similar reason. The corollary to this however is that the rates achievable are 
very low and so rapid (> 1 °C/minute) rates are very hard to achieve. In addition, alcohol 
bath freezers are normally limited to temperatures above -80 °C. 
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3.3 Liquid nitrogen vessels: Liquid and vapour 
Storage of important biomaterial in liquid nitrogen at -196 °C is widely practised. This 
method allows for a 70 °C plus safety zone when considering the -120 °C threshold for long-
term storage; the significance of -120 °C, the glass transition temperature, has been 
previously discussed. Liquid nitrogen storage does provide the greatest safety zone. 
However, it also presents a number of problems, including personal safety and potential 
microbiological cross-contamination via the liquid nitrogen. 
Storage in the vapour stage is felt to address these issues but it does come with its own set of 
problems. The vapour is not as cold as the liquid nitrogen itself and as such the 70 °C safety 
margin is diminished. However, modern vapour storage vessels use carefully designed 
vacuum insulation to minimise the heat leakage from the environment into the vessel. This 
allows the vessel to maintain a vapour temperature at around -190 °C resulting in samples 
still being maintained at a safe distance from the glass transition temperature. Efficient 
designs also result in very low liquid nitrogen usage and temperatures can be maintained 
for up to a month without additional filling; temperatures are even maintained with the lid 
removed for short periods. 
3.4 Controlled rate liquid nitrogen freezers 
As described previously, up to present times, the controlled rate freezer offers the widest 
control options for a freezing protocol. With a truly variable application system for cryogen, 
most sample sizes can be easily accommodated and rates from the very slow (< 0.1 °C/minute) 
to in excess of 50 °C/minute are both achievable and controllable. Sample size, container 
dimension, cell volume, membrane permeability etc. are all variable factors. As the controlled-
rate freezer allows complex, fully controlled temperature versus time profiles to be created, 
protocols can be designed that are appropriate to the cell type and cryoprotectant 
concentration. Additional steps such as pauses for manual 'seeding' or rapid plunges to 
initiated freezing can be added to the profile. Transition to different rates can be triggered 
from the chamber temperature or representative sample; triggering the transition from the 
sample temperature can help remove variability introduced by different sample loads.. 
From an instrumentation standpoint, the programming and record-keeping intrinsic within 
the system meet most external compliance standards and optional software packages are 
generally available to enhance this aspect beyond the current requirements of any legislative 
authority. The fact that it is possible to optimise processes for every unique cell type 
together with the compliance aspect lend great versatility to this type of instrument in most 
application areas. 
3.5 Equipment for conventional (high cooling rate) vitrification 
Such protocols call for extremely rapid solidification of the sample, typically by plunging it 
directly, and in a somewhat uncontrolled manner, into liquid nitrogen. Intracellular ice 
formation is avoided by the application of very high concentrations of CPA. Equipment 
such as the VitMaster (IMT ltd.) can be used to increase the cooling rate. This uses negative 
pressure to depress the freezing point of liquid nitrogen to below -205 °C thereby increasing 
the cooling rate. Several open techniques have been developed to minimise the sample 
volume and achieve high cooling rates; for example the Cryotop method which uses a thin 
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film strip to hold the sample. These open systems typically expose the sample directly to the 
liquid nitrogen which assists in achieving the very high cooling rates. Of course exposing 
the sample directly to liquid nitrogen in this manner raises questions of potential 
contamination from the cryogen. Other approaches, such as the Cryologic Vitrification 
Method, still use an open device at the stage of vitrification but cool the sample by touching 
on a liquid nitrogen cooled aluminium block. This means that the sample is not directly 
exposed to the liquid nitrogen and the block avoids the Leidenfrost effect. Alternative 
approaches use closed straws. These avoid the contamination issues but at the expense of 
the cooling rate. By definition, the vitrification stage of the process is difficult to measure, 
monitor or document, so validation and on-going quality control are qualitative exercises 
only. 
3.6 Stirling engines 
Originally conceived in 1816 by the Reverend Stirling, the Stirling engine converts heat 
energy into mechanical work. The principal also works the other way round to convert 
mechanical energy to heat, when the Stirling engine forms a heat pump able to move heat 
'uphill' from a cold place to a warmer one. This gives the Stirling engine an application as a 
refrigeration unit. 
Most refrigerators operate on the Rankine cycle which depends on refrigerants existing with 
appropriate boiling points. Triple stage Rankine machines are at the limit of the technology 
and achieve roughly -140 °C. Although the Stirling cycle is less efficient than Rankine cycle 
machines, it is capable of cooling to lower temperatures and therefore comes into its own 
below -140 °C; miniature cryo-coolers based on Stirling engines are now quite common. Due 
to relative inefficiency, these Stirling based cryo-coolers can normally freeze only quite small 
samples of a few tens of grams maximum and cannot compete with liquid nitrogen powered 
machines for cooling capacity. On the other hand, they excel in clean rooms where it is not 
possible to obtain a supply of liquid nitrogen and it is only desired to freeze very small 
samples. 
3.7 Liquidus tracking equipment 
Because liquidus tracking is a relatively novel technique, there is little choice of 
equipment to assist with research into its use. Planer plc do manufacture a Liquidus 
Tracking controller that can be used for research into this approach. The equipment 
comprises a conventional slow-rate chamber coupled with a liquidus tracking controller 
and two peristaltic pumps. 
The controller cools the sample in a similar manner to the conventional slow-rate freezing 
process. The cooling profile is typically a simple linear ramp. During the cooling of the 
sample, the controller monitors the current chamber temperature and adjusts the speeds of 
the two pumps to dynamically alter the concentration of cryoprotectant surrounding the 
samples. In the ideal process the concentration of cryoprotectant is maintained just above 
the liquidus curve. As the temperature decreases, the concentration of cryoprotectant is 
therefore increased. However, as the temperature of the sample decreases, the toxicity of the 
cryoprotectant decreases and this allows the sample to tolerate the ever increasing 
concentrations; see figure 1. 
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Fig. 1. Concentration of sample tracking liquidus 
Two specific requirements of this process are the rather large volumes of cryoprotectant 
required and the need to ensure good mixing around the sample. The Planer Liquidus 
Tracker supports two modes of operation each with its own advantages and disadvantages; 
these are the single solution and dual solution modes. 
In the dual solution mode, shown in figure 2, a solution containing a high concentration of 
CPA (typically 72 % w/w DMSO plus isotonic salts) and a solution containing only isotonic 
salts (nominal 0 % solution) are used. Each solution is  pumped through a mixing junction 
and a heat exchanger into the sample container and thence into a waste collection container. 
The relative speeds of the pumps are continuously adjusted via a computer program to 
deliver the correct concentration to the sample. The pump speeds are adjusted to maintain a 
constant flow rate through the sample container. The dual solution system requires a small 
volume surrounding the sample so that the incoming, premixed solution is able to displace 
the existing solution completely as it flows through the container. The total volume of 
cryoprotectant can be quite large; for example, a run from 0 °C to -70 °C at 0.3 °C/minute 
requires a total volume of solution equal to 233 times the sample container volume. This 
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method is suitable for use with small sample containers and has been used for discs of ovine 
articular cartilage ( see Wang et al.,  2007). 
 
Fig. 2. Dual solution mode. 
The single solution mode is more suitable for use with larger samples. It is illustrated in 
figure 3. Here a highly concentrated solution is cooled and delivered to the sample 
container. This increases the concentration of the CPA solution surrounding the sample. To 
maintain a constant volume within the container, the second pump extracts the excess 
solution from the container. This technique is suitable for larger samples as it reduces the 
total volume of cryoprotectant required. For a sample container volume of Vs, a 
cryoprotectant concentration of Ksol and a target concentration of Kt, the volume of 
cryoprotectant V can be calculated from this equation.  
 V = Vs.ln(Ksol / (Ksol – kt))  (1) 
For a sample container volume of 50 ml, depending on the actual values of Ksol and Kt this 
approach could require less than 100 ml of concentrated DMSO solution. Because the 
incoming solution has to be thoroughly mixed within the container, additional stirring 
equipment running at cryogenic temperatures is required. This results in a mechanically 
more complex arrangement than the dual solution approach. 
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Fig. 3. Single solution mode. 
3.8 Examples of equipment used 
The BioCool Controlled Rate Freezer from FTS Systems/SP Scientific is a mechanically 
refrigerated bath with temperature control to -40 °C or -80 °C. The fluid in the 2 litre bath 
provides temperature stability and dispersion of the heat of fusion without a concomitant 
temperature rise. Courtesy SP Scientific and Gary Gold Photography. 
 
BioCool™ Controlled Rate Freezer 
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The Asymptote EF600, a unique liquid nitrogen free, controlled-rate freezer, is electrically 
powered by a Stirling Cycle Cryocooler rather than liquid nitrogen. This allows the freezer 
to be used where liquid nitrogen is in short supply, where extra high air quality is needed, 
or where there is a risk of LN2 contamination to samples. 
 
 
 
 
Asymptote liquid nitrogen free controlled-rate freezer 
The Planer Kryo 360 cell freezer controls down to a -180 °C end temperature to ensure 
sample integrity during transfer to storage. Fully programmable, it allows the use of 
protocols associated with the most advanced cryopreservation techniques and is widely 
used in laboratories around the world. 
 
 
 
 
Planer Kryo 360 programmable cell freezer 
The Crysalys controlled rate freezer: programmes, time and temperatures may be entered 
via a touch screen with up to 100,000 cycles held on the onboard SD card; the data can be 
retrieved by any PC or Mac computer. A battery back up operates the system for 3 hours; its 
portability and 3.2 kg weight make it especially suited to veterinary purposes. 
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Crysalys controlled rate freezer 
The Gemini Tinytag View 2 data logger, when used with a specially designed probe, is used 
for temperature monitoring in cryogenic environments down to -200 °C. 
 
Tinytag View 2 data logger 
The CoolCell is an alcohol-free cell freezing container which provides a reproducible cooling 
rate of 1 °C/minute when placed in a -80 °C freezer. No alcohol is required to control the 
freeze rate as the design and materials of the CoolCell ensure precise and uniform heat 
removal from cryovials. 
 
CoolCell®, an alcohol-free cell freezing container 
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The Planer ShipsLog is a datalogger specifically designed for vapour shippers, which 
maintains a downloadable temperature history of samples during transit. 
 
 
ShipsLog datalogger for vapour shippers 
The Liquidus Tracker is a new controlled vitrifier for cryopreservation of samples using the 
liquidus tracking technique. This approach may have uses in vitrifying larger samples and 
those which are currently difficult to cryopreserve. 
 
 
Liquidus Tracker controlled vitrifier for cryopreservation 
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